<DOC>
	<DOCNO>NCT02182726</DOCNO>
	<brief_summary>The aim study investigate - indication MOBEC dose 15 mg per day - treatment patient receive switch 15 mg MOBEC - treatment 15 mg assess compare previous treatment - effective safe treatment 15 mg MOBEC consider</brief_summary>
	<brief_title>Postmarketing Surveillance Study With MOBECÂ®</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<criteria>An indication treatment 15 mg MOBEC least four week symptomatic shortterm treatment osteoarthritis symptomatic longterm treatment rheumatoid arthritis ( chronic polyarthritis ) ; restriction : recommend dose longterm treatment elderly patient 7.5 mg ) symptomatic treatment ankylose spondylitis Treatment MOBEC prior start study Patients general specific contraindication MOBEC</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>